Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia
This study is ongoing, but not recruiting participants.
Study NCT00607451   Information provided by Neurim Pharmaceuticals Ltd.
First Received: January 22, 2008   Last Updated: August 25, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Levodopa-induced Dyskinesia
Additional conditions recognized in this trial
Dyskinesias
Parkinson Disease
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Neurologic Manifestations
Parkinsonian Disorders
Signs and Symptoms
Interventions listed in this trial
Neu-120
Sponsors listed in this trial
Neurim Pharmaceuticals Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services